Sanjay Thamake

1.2k total citations
28 papers, 791 citations indexed

About

Sanjay Thamake is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sanjay Thamake has authored 28 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sanjay Thamake's work include Cancer, Hypoxia, and Metabolism (10 papers), Renal cell carcinoma treatment (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Sanjay Thamake is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Renal cell carcinoma treatment (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Sanjay Thamake collaborates with scholars based in United States, Denmark and United Kingdom. Sanjay Thamake's co-authors include Jamboor K. Vishwanatha, Amalendu P. Ranjan, Sangram Raut, Zygmunt Gryczyński, Ebrahim S. Delpassand, Izabela Tworowska, David Ranganathan, Alireza Mojtahedi, Pankaj Chaudhary and Praveenkumar Shetty and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Sanjay Thamake

28 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanjay Thamake United States 15 334 235 161 154 142 28 791
Mariana Scaranti Brazil 9 269 0.8× 323 1.4× 111 0.7× 70 0.5× 123 0.9× 25 832
Quan P. Ly United States 19 331 1.0× 405 1.7× 141 0.9× 188 1.2× 108 0.8× 42 922
Eunsung Jun South Korea 20 331 1.0× 619 2.6× 236 1.5× 196 1.3× 137 1.0× 71 1.1k
Jennifer Sims‐Mourtada United States 16 515 1.5× 529 2.3× 132 0.8× 153 1.0× 86 0.6× 34 1.0k
Donghai Huang China 24 815 2.4× 380 1.6× 138 0.9× 377 2.4× 83 0.6× 60 1.3k
Tatsuya Manabe Japan 18 245 0.7× 544 2.3× 157 1.0× 153 1.0× 87 0.6× 63 1.0k
Xianghua Wu China 17 583 1.7× 523 2.2× 341 2.1× 196 1.3× 124 0.9× 71 1.3k
Jonathan G. Sham United States 15 193 0.6× 339 1.4× 93 0.6× 76 0.5× 231 1.6× 31 865
G. Kesava Reddy United States 12 254 0.8× 234 1.0× 135 0.8× 56 0.4× 116 0.8× 55 693
Nai‐Jung Chiang Taiwan 18 268 0.8× 367 1.6× 234 1.5× 117 0.8× 111 0.8× 87 874

Countries citing papers authored by Sanjay Thamake

Since Specialization
Citations

This map shows the geographic impact of Sanjay Thamake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjay Thamake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjay Thamake more than expected).

Fields of papers citing papers by Sanjay Thamake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjay Thamake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjay Thamake. The network helps show where Sanjay Thamake may publish in the future.

Co-authorship network of co-authors of Sanjay Thamake

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjay Thamake. A scholar is included among the top collaborators of Sanjay Thamake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjay Thamake. Sanjay Thamake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Todd M., Toni K. Choueiri, Kyriakos P. Papadopoulos, et al.. (2021). The oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma (RCC): Updated follow-up of a phase I/II study.. Journal of Clinical Oncology. 39(6_suppl). 273–273. 21 indexed citations
2.
Srinivasan, Ramprasad, Frede Donskov, Othon Iliopoulos, et al.. (2020). LBA26 Phase II study of the oral HIF-2α inhibitor MK-6482 for Von Hippel-Lindau (VHL) disease-associated clear cell renal cell carcinoma (ccRCC): Update on RCC and non-RCC disease. Annals of Oncology. 31. S1158–S1158. 3 indexed citations
3.
Choueiri, Toni K., Elizabeth R. Plimack, Todd M. Bauer, et al.. (2020). Phase I/II study of the oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma (RCC).. Journal of Clinical Oncology. 38(6_suppl). 611–611. 33 indexed citations
4.
Jonasch, Eric, et al.. (2019). An open-label phase II study to evaluate PT2977 for the treatment of von Hippel-Lindau disease-associated renal cell carcinoma.. Journal of Clinical Oncology. 37(7_suppl). TPS680–TPS680. 9 indexed citations
5.
Jonasch, Eric, Elizabeth R. Plimack, Todd M. Bauer, et al.. (2019). A first-in-human phase I/II trial of the oral HIF-2a inhibitor PT2977 in patients with advanced RCC. Annals of Oncology. 30. v361–v362. 9 indexed citations
6.
Jonasch, Eric, et al.. (2018). An open-label phase II study to evaluate PT2977 for the treatment of von hippel-lindau disease associated renal cell carcinoma. Annals of Oncology. 29. viii328–viii328. 1 indexed citations
7.
Chaudhary, Pankaj, Sanjay Thamake, Sayantan Maji, et al.. (2016). Rationalizing the Use of Functionalized Poly-Lactic-Co-Glycolic Acid Nanoparticles for Dendritic Cell-Based Targeted Anticancer Therapy. Nanomedicine. 11(5). 479–494. 36 indexed citations
8.
Tworowska, Izabela, David Ranganathan, Sanjay Thamake, et al.. (2015). Radiosynthesis of clinical doses of 68 Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based 68 Ge/ 68 Ga generators. Nuclear Medicine and Biology. 43(1). 19–26. 23 indexed citations
9.
Mojtahedi, Alireza, Abass Alavi, Sanjay Thamake, et al.. (2015). Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.. PubMed. 5(1). 65–71. 34 indexed citations
10.
Chaudhary, Pankaj, et al.. (2014). Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies. British Journal of Cancer. 111(12). 2328–2341. 45 indexed citations
11.
Ranganathan, David, Sanjay Thamake, Izabela Tworowska, & Ebrahim S. Delpassand. (2014). Ga-68 based PET tracers for diagnosis of malignant tumors. 55. 1003–1003. 1 indexed citations
12.
Mojtahedi, Alireza, Sanjay Thamake, Izabela Tworowska, David Ranganathan, & Ebrahim S. Delpassand. (2014). The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.. PubMed. 4(5). 426–34. 123 indexed citations
13.
Thamake, Sanjay, et al.. (2013). Intranasal delivery of nanoparticle-based vaccine increases protection against S. pneumoniae. Journal of Nanoparticle Research. 15(5). 4 indexed citations
14.
Shetty, Praveenkumar, Sanjay Thamake, Swati Biswas, Sonny L. Johansson, & Jamboor K. Vishwanatha. (2012). Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer. PLoS ONE. 7(9). e44299–e44299. 61 indexed citations
15.
Shetty, Praveenkumar, Sanjay Thamake, Swati Biswas, Sonny L. Johansson, & Jamboor K. Vishwanatha. (2012). Correction: Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer. PLoS ONE. 7(9). 12 indexed citations
16.
Thamake, Sanjay, Sangram Raut, Zygmunt Gryczyński, Amalendu P. Ranjan, & Jamboor K. Vishwanatha. (2012). Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials. 33(29). 7164–7173. 158 indexed citations
17.
Ranjan, Amalendu P., et al.. (2011). A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging. Nanotechnology. 22(29). 295104–295104. 17 indexed citations
18.
Valapala, Mallika, Sanjay Thamake, & Jamboor K. Vishwanatha. (2011). A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. Journal of Cell Science. 124(9). 1453–1464. 42 indexed citations
19.
Thamake, Sanjay, Sangram Raut, Amalendu P. Ranjan, Zygmunt Gryczyński, & Jamboor K. Vishwanatha. (2010). Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy. Nanotechnology. 22(3). 35101–35101. 54 indexed citations
20.
Sarkar, Pabak, Rafał Luchowski, Sangram Raut, et al.. (2010). Studies on solvatochromic properties of aminophenylstyryl-quinolinum dye, LDS 798, and its application in studying submicron lipid based structure. Biophysical Chemistry. 153(1). 61–69. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026